In addition, we found through the GEPIA2 website that LIPT2 expression had an impact on the pathological staging of KIRC, Thyroid carcinoma (THCA), and Liver hepatocellular carcinoma (LIHC) patients (Supplementary Fig. 1a). The gene discussed is LIPT2; the disease is thyroid gland carcinoma.